On Tuesday, MarketAxess Holdings Inc. (NASDAQ:MKTX)’s shares declined -3.71% to $93.33.
MarketAxess Holdings Inc. (MKTX), the operator of a leading electronic trading platform for fixed-income securities, and the provider of market data and post-trade services for the global fixed-income markets, declared total monthly trading volume for September 2015 of $82.4 billion, compriseing of $47.6 billion in U.S. high-grade volume, $29.6 billion in other credit volume, and $5.3 billion in liquid products volume.
MarketAxess is providing both the stated and adjusted estimated U.S. high-grade TRACE volumes on its website. The Company believes that the adjusted estimated volumes provide a more accurate comparison to preceding period reporting.
Marketaxess Holdings Inc., together with its auxiliaries, operates an electronic trading platform that enables fixed-income market participants to trade corporate bonds and other types of fixed-income instruments worldwide.
Abeona Therapeutics Inc (NASDAQ:ABEO)’s shares dropped -5.41% to $4.02.
Abeona Therapeutics, Inc. (ABEO), a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases, declared a license agreement with Stanford University for an AAV (adeno-associated virus) delivery vector for the treatment of Fanconi anemia (FA) and rare blood disease platform. This license augments a formerly declared license agreement with the University of Minnesota for ABO-301 (AAV-FANCC) to treat patients with Fanconi anemia (FA) disorder and other rare blood diseases.
The major function of bone marrow is to produce new blood cells. In FA, a DNA mutation renders the FANCC gene nonfunctional. Loss of FANCC causes patient skeletal abnormalities and leads to bone marrow failure. Fanconi anemia patients also have much higher rates of hematological diseases, such as acute myeloid leukemia (AML) or tumors of the head, neck, skin, gastrointestinal system, or genital tract. The likelihood of developing one of these cancers in people with Fanconi anemia is between 10 and 30 percent. Aside from bone marrow transplantation (BMT) there are no specific treatments known that can halt or reverse the symptoms of FA. Repairing fibroblast cells in FA patients with a functional FANCC gene is the focus of our AAV-based gene therapy approach.
Abeona Therapeutics Inc., a biopharmaceutical company, focuses on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases.
At the end of Tuesday’s trade, Yelp Inc (NYSE:YELP)‘s shares surged 0.04% to $22.69.
Yelp Inc. (YELP), the company that connects consumers with great local businesses, declared the election of current board member, Diane Irvine, to the position of non-executive board chairperson, effective right away. Irvine takes over from Max Levchin, who recently stepped down from Yelp’s and other boards to dedicate more time to the company he founded and leads.
Diane is also a board member of XO Group Inc., a consumer internet and media company, and of Rightside Group, Ltd., a leading provider of domain name services. She formerly served as an executive of Blue Nile, Inc., the leading online retailer of diamonds and fine jewelry, from 1999-2011, having joined Blue Nile as chief financial officer and later serving as chief executive officer, president and a director on the board. Diane has also served as chief financial officer of Plum Creek Timber Company, a timberland administration and wood products company, and was a tax partner at international accounting firm, Coopers & Lybrand LLP.
Yelp Inc. operates a platform that connects people with local businesses in the United States. Its platform covers various local business categories, counting restaurants, shopping, beauty and fitness, arts, entertainment and events, home and local services, health, nightlife, travel and hotel, auto, and others categories.
Praxair, Inc. (NYSE:PX), ended its Tuesday’s trading session with -0.35% decreased, and closed at $105.97.
Praxair, Inc. (PX) will release its third quarter 2015 financial results on Thursday, October 29, 2015, before the market opens and will host a conference call at 11:00 a.m. ET that morning. Following are details for the listen-only conference call, which will be accessible live and on demand to the public and the media.
Praxair, Inc. produces, sells, and distributes atmospheric, process, and specialty gases, in addition to surface coatings in North America, Europe, South America, and Asia.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
